Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSX:
$TRST.TO) (NYSE: $CTST) (CSE: $OILS.C) (OTCQB: $OILFF) (CSE:
$BEV.C) (TSX: $FAF.TO)
Delta, Kelowna, BC –September 23 , 2019
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/09232TRST-CTST-OILS-OILFF-BEV-FAF.asp
Today's podcast overview/transcript
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In
today’s podcast we look at a few early announcements.
But
first, looking back at the big news from last week which was from CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST) who received a
Notice of Licence Suspension under section 64(1) of the Cannabis Act. The Notice cites the Company's previous non-compliance
with certain requirements of the Cannabis Act and the regulations made thereunder in respect of
the matters that the Company has been discussing with Health Canada. The
company then received notice from the Alberta Gaming, Liquor and
Cannabis Commission, the Crown corporation in charge of wholesale distribution
of cannabis products to licensed cannabis retailers in Alberta, advising the
Company that the AGLC has determined that the Company's products sold to the
AGLC will be returned to the Company pursuant to the terms of the Cannabis
Supply Agreement between the Company and the AGLC. Under the terms of the Supply Agreement,
goods sold to the AGLC may be returned to the Company for any reason and the
Company will be responsible for the cost of the goods and all expenses related
to the return.
The
products to be returned constitute all or substantially all of the Company's
products currently held at the AGLC and are valued at approximately $1.3
million in the aggregate. The AGLC
operates independently of Health Canada.
Health Canada has not ordered a recall in respect of any of the
Company's products.
CannTrust
remains fully focused on achieving complete regulatory compliance. The Company
is committed to rebuilding the trust of all stakeholders, and looks forward to
delivering high quality, innovative products to both its patients and customers
in the future.
Nextleaf Solutions
Ltd. (CSE: OILS) (OTCQB: OILFF) announced today it has entered into an agreement to
acquire intellectual property pertaining to water-soluble cannabinoid
formulations. Based around a Nano and Micro Emulsification process, the
technology utilizes food grade emulsifiers already approved by Health Canada.
These water-soluble cannabinoids are shelf stable, resulting in no constituent
separation, and boast a rapid onset time.
"This
nanotechnology increases onset time from over 90 minutes to less than 10
minutes when consuming cannabinoids in a beverage. We believe this represents a
quantum leap for the industry, as fast onset is a pre-requisite for mass market
acceptance of THC and CBD infused drinks." said Paul Pedersen, CEO of
OILS.
Under
the agreement, OILS will acquire the processing methodology and ingredient
formulation from a private company led by a team with extensive experience in
emulsifying hydrophobic molecules into various matrixes. The developers combine
expert chemical engineering with tenured experience from one of the largest
Canadian dairy product manufacturers. "This is a cannabis specific
innovation built on proven and validated food and beverage technology,"
said Ryan Ko, Chief Technology Officer of Nextleaf Solutions. "The
technology and formulation allow for versatile application into hot or cold
liquids, semi-solid, or solid mediums. Homogeneity is crucial for a reliable
consumer experience so that every bite or sip delivers a consistent amount of
cannabinoids."
The
Company's proprietary extraction, purification and refinement system paired
with the newly acquired water-soluble formulation gives a superior advantage to
Nextleaf's commercialization partners as products will represent cleaner
ingredient profiles, minimizing the use of additives for flavor masking. OILS
has granted an exclusive license to BevCanna
Enterprises Inc. (CSE: BEV), a BC-based emerging leader in
cannabis-infused beverages, for the use of intellectual property related to
water-soluble cannabinoids for the development, manufacturing and sale of
BevCanna products. Nextleaf also has a supply agreement with BevCanna to
provide cannabinoids for the production of their products.
As
consumer packaged goods companies enter the cannabis infused product landscape,
OILS believes the scalability of its patented technology and ability to
standardize ingredients is what sets it apart. Paul Pedersen, CEO of Nextleaf
Solutions, "as the industry evolves, there's going to be increased demand
for more sophisticated processing solutions to formulate standardized
products."
Fire & Flower
Holdings Corp. and its
wholly-owned subsidiary Fire & Flower Inc. (TSX: FAF), today announced that its Chief Executive Officer, Trevor
Fencott has been elected to the Board of Directors of the Canadian Chamber of
Commerce.
As
the "Voice of Canadian Business", the Canadian Chamber of Commerce is
Canada's largest and most recognized business association in the country, which
speaks with one unified voice on behalf of nearly a quarter million businesses.
Since 1925, the Chamber has connected businesses of all sizes, from all sectors
and from all regions of the country to advocate for public policies that will
foster a strong, competitive economic environment that benefits businesses,
communities and families across Canada. Most recently, the Chamber formed a
National Cannabis Working Group to provide balanced policy recommendations
supporting Canada's emerging cannabis sector.
"The
Canadian Chamber of Commerce is very pleased to welcome Mr. Fencott to the
Board of Directors. Mr. Fencott is a pioneering voice of the legal cannabis
industry in Canada and Fire & Flower is regarded as a leader in this
emerging market," shared Perrin Beatty, PC, OC, President and Chief Executive
Officer of the Canadian Chamber of Commerce.
"It
is an honour to represent the Canadian cannabis industry on the board of the
Canadian Chamber of Commerce alongside some of Canada's most recognized and
respected companies. The progressive outlook demonstrated by the Chamber in
forming a National Cannabis Working Group is to be commended and Fire &
Flower is proud to be co-chairing the initiative. Working with the Chamber
creates the unique opportunity for the cannabis sector to access the nationwide
Chamber network and put forward non-partisan, balanced policy recommendations
that will allow the industry to move to the next level of its national and
international development," shared Trevor Fencott, Chief Executive Officer
of Fire & Flower.
Further
details on the Canadian Chamber of Commerce policy work as it relates to the
emerging cannabis industry will be published on the organization's website at www.chamber.ca.
Jushi Holdings Inc. (NEO: JUSH.B) (OTCQX: JUSHF),
a globally-focused, multi-state cannabis and hemp operator, announced that the OTC Markets Group has approved
the trading of the Company's subordinate voting shares on its OTCQX® Best
Market under the ticker symbol 'JUSHF'. Jushi's subordinate voting shares will
begin trading on the OTCQX® Market at the opening of the market today,
September 23, 2019. The Company's subordinate voting shares will continue to be
listed on the Neo Exchange Inc. under the ticker symbol 'JUSH.B'.
"Trading
our shares on the OTCQX® Market, the premier tier of the OTC market, will raise
the Company's profile by diversifying our shareholder base and enhancing share
liquidity in support of our Company's long-term objectives. Qualifying to trade
on the OTCQX® Market reflects our commitment to holding our Company to the
highest standards of disclosure, corporate governance, and compliance,"
said Jim Cacioppo, CEO and Chairman of Jushi Holdings Inc.
Curaleaf
New York, a subsidiary of Curaleaf
Holdings Inc. (CSE: CURA) (OTC: CURLF) launched Curaleaf Ground Flower Pods - New York
State's first medical cannabis flower products – at its Carle Place dispensary
in Nassau County, Long Island. The product will be available at all four
Curaleaf dispensaries in the coming weeks.
Now
available for limited release, Curaleaf will provide New York's medical
cannabis patients a new method to take their medicine by offering ground flower
pods which are used in medical vaporizers. Each Curaleaf Ground Flower Pod
contains 350mg of active cannabinoids – a total of 700mg per 3.5g package – in
a 20:1 THC:CBD ratio in Indica and Sativa strains.
"Curaleaf
is very pleased to be launching the first medical cannabis flower products to
be offered in New York state, which is first and foremost a win for our
patients," said Joseph Lusardi, CEO of Curaleaf. "Flower is cannabis in its raw form and
therefore the most affordable form of cannabis. We can increase patient access
by providing more affordable products and offering more options for patients in
the medical program. We'd like to thank the Department of Health for permitting
us to sell vapable flower. We believe it's an important step toward making
natural products available in New York."
"As
a practitioner in the Long Island area, I strive to help patients attain the
most effective medicine to treat their conditions," said Dr. Grace Forde,
MD, Director of Neurological Services at North American Partners in Pain
Management in Long Island. "It's extremely beneficial to patients to offer
more options beyond cannabis oil. In addition to being more affordable and
all-natural, vaporizing cured ground flower cannabis produces effects faster
than oral solutions and is therefore better suited for treating certain medical
conditions."
Starting
today, the Curaleaf Tabletop Vaporizer is also available for purchase. The
Curaleaf Tabletop Vaporizer heats the ground cannabis to a point below
combustion where the contents are released in a mild, smokeless vapor, enabling
inhalation without the by-products of smoking.
Further
demonstrating the company's commitment to expanding patient access, Curaleaf
New York launched its delivery program earlier this year. The program, free
with purchase, which runs three days a week on Thursdays, Fridays and
Saturdays, is available to registered patients and their caregivers living in
Nassau, Suffolk, Queens, Kings and New York Counties.
Valens GroWorks
Corp. (TSXV: VGW) (OTCQX: VGWCF) announced that it has received an amended license
from Health Canada and continues to make significant progress with the build
out of the adjoining state of the art white label manufacturing facility
scheduled for completion by H1 2020.
Under
the new license, Valens is now authorized to manufacture and supply oil
products directly to provincial distributors and other authorized Canadian
retail supply channels. Valens will immediately start leveraging this amended
license to expand services provided to its white label manufacturing partners,
delivering retail ready products including tinctures and gel caps. The Company plans to further expand its
retail ready product offerings to include vaporizer cartridges, beverages,
topicals and other desired products as permitted by Health Canada.
"This
amended license represents another significant milestone for the Company"
said Tyler Robson, CEO of Valens. "We are excited to be able to utilize
this license, our industry leading extraction, IP and formulation services
along with our strategic partnerships with companies like Shoppers Drug Mart,
to provide our white label partners access to a comprehensive service
offering."
"With
Valens now licensed to manufacture and supply white label products through
provincial distributors we are happy to update investors on the construction of
the adjoining state of the art white label facility which remains on time and
on budget to be complete by H1 2020" said Tyler Robson.
Valens
has already built out the capability to fulfill initial white label product
demand through the Company's current extraction and product development
facility. However, the new white label manufacturing facility is not only
expected to increase extraction capacity to over 1,000,000kg per year through
further expansion of the Company's ethanol and hydrocarbon capabilities but
will substantially increase product development and manufacturing volumes of
vape pens, beverages, concentrates, edibles, and topicals for its customers.
The new facility will include robotics and automated machinery to enhance
throughput and efficiencies of customized products for our customers.
"This
is a purpose-built facility to EU GMP standards and is expected to be one of
the largest and most diverse third-party cannabis product development
facilities in Canada" said Tyler Robson. "We will be expanding our offerings
to our customers to also include customized formulations, emulsion, terpene
enhancement, and centrifugal partition chromatography that will allow our
customers to target specific desired cannabinoids as the market offerings
mature, such as CBG, THCV or CBN, as well as separate out unwanted contaminants
in oil including pesticides and microbials."
The
Company would also like to provide further insight into the strategic
agreement, announced on September 16, 2019, with Shoppers Drug Mart for the supply
of cannabis oil products. Under the
terms of the agreement, Shoppers will purchase from the Company, retail ready
products including gel caps and tinctures for sale and distribution on their
medical cannabis ecommerce site, with further expansion of product offerings to
include vaporizer cartridges, topicals and other desired products as permitted
by Health Canada. The agreement is for an initial three-year term, with the
option to renew for an additional two years with the total value of the contract
being determined based on the size and frequency of purchase orders received by
the Company from Shoppers. The Company already has all the infrastructure in
place to execute under the agreement and continues to work closely with the
team at Shoppers to finalize details for the successful launch of products.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
